Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by 13C-methionine breath test

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 4, 2008, Pages 443-449

  Banasch, M ^a   Emminghaus, R ^a   Ellrichmann, M ^a   Schmidt, W E ^a   Goetze, O ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; METHIONINE; METHIONINE C 13; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY VIROLOGICAL RESPONSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER MITOCHONDRION; LONGITUDINAL STUDY; MALE; METHIONINE BREATH TEST; NON INVASIVE MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REFERENCE VALUE; TREATMENT RESPONSE; VIRUS CELL INTERACTION;

ADULT; ANTIVIRAL AGENTS; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LIVER FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; METHIONINE; MIDDLE AGED; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; PREDICTIVE VALUE OF TESTS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 47749095589     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03745.x     Document Type: Article

References (21)

1. Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J 2005 24 : 755 60.
2. Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002 122 : 366 75.
3. Korenaga M, Wang T, Li Y, et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005 280 : 37481 8.
4. Piccoli C, Scrima R, Quarato G, et al. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 2007 46 : 58 65.
5. Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J 2007 21 : 2474 85.
6. Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003 362 : 1708 13.
7. Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998 27 : 1730 5.
8. Miele L, Grieco A, Armuzzi A, et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003 98 : 2335 6.
9. Mion F, Rousseau M, Brazier JL, Minaire Y. Human hepatic macrovesicular steatosis: a noninvasive study of mitochondrial ketoisocaproic acid decarboxylation. Metabolism 1995 44 : 699 700.
10. Milazzo L, Piazza M, Sangaletti O, et al. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 2005 55 : 84 9.
11. Candelli M, Cazzato IA, Zocco MA, et al. 13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci 2004 8 : 23 31.
12. Banasch M, Goetze O, Hollborn I, et al. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr 2005 40 : 149 54.
13. Banasch M, Goetze O, Knyhala K, et al. Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients. Aids 2006 20 : 1554 6.
14. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 9.
15. Pinheiro J, Bates D Mixed-effects Models in S and S-PLUS. New York, Berlin, Heidelberg : Springer, 2000 : 1 197.
16. Akaike H. A new look at statistical model identification. IEEE Trans Autom Contr 1974 19 : 716 23.
17. Lewis JA, Huq A, Najarro P. Inhibition of mitochondrial function by interferon. J Biol Chem 1996 271 : 13184 90.
18. Lechner J, Malloth N, Seppi T, Beer B, Jennings P, Pfaller W. IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium. Am J Physiol Cell Physiol 2008 294 : C153 60.
19. Bani-Sadr F, Carrat F, Pol S, et al. Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr 2005 40 : 47 52.
20. Mauss S, Valenti W, DePamphilis J, et al. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. Aids 2004 18 : F21 5.
21. Bauerle J, Laguno M, Mauss S, et al. Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection? HIV Med 2005 6 : 135 9.